back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-10-14 Tx date 2017-10-12 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$30,000
+150,000 vol $0.20 each |
396,000 | |
| Filed 2017-10-13 Tx date 2017-10-10 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-30,000
-150,000 vol $0.20 each |
0 | |
| Filed 2017-07-04 Tx date 2017-06-29 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$5,250
+105,000 vol $0.05 each |
246,000 | |
| Filed 2017-05-06 Tx date 2017-05-05 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-5,250
-105,000 vol $0.05 each |
150,000 | |
| Filed 2017-01-27 Tx date 2017-01-26 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$1,500
+30,000 vol $0.05 each |
141,000 | |
| Filed 2017-01-25 Tx date 2017-01-25 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+150,000 vol $0.20 each |
255,000 | |
| Filed 2017-01-02 Tx date 2016-12-29 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,500
-30,000 vol $0.05 each |
105,000 | |
| Filed 2016-09-29 Tx date 2016-09-22 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Indirect Ownership)
|
Common Shares
51 - Exercise of options
|
$1,750
+35,000 vol $0.05 each |
111,000 | |
| Filed 2016-09-29 Tx date 2016-09-22 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,750
-35,000 vol $0.05 each |
135,000 | |
| Filed 2016-08-03 Tx date 2016-07-22 |
$RJX
RJK Explorations Ltd. |
Layman, David J
4 - Director of Issuer
Holder: Deux Freres Limited (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-31,050 vol |
3,450 | |
| Filed 2016-08-03 Tx date 2016-08-03 |
$RJX
RJK Explorations Ltd. |
Layman, David J
4 - Director of Issuer
Holder: Atlantic Settlement Holdings Corporation (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,000
-5,000 vol $0.20 each |
17,200 | |
| Filed 2016-08-03 Tx date 2016-07-22 |
$RJX
RJK Explorations Ltd. |
Layman, David J
4 - Director of Issuer
Holder: Atlantic Settlement Holdings Corporation (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-199,800 vol |
22,200 | |
| Filed 2016-05-17 Tx date 2016-05-11 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-2,000
-40,000 vol $0.05 each |
170,000 | |
| Filed 2016-05-17 Tx date 2016-05-11 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$2,000
+40,000 vol $0.05 each |
76,000 | |
| Filed 2016-02-04 Tx date 2016-01-04 |
$RJX
RJK Explorations Ltd. |
Layman, David J
4 - Director of Issuer
Holder: Deux Freres Limited (Control or Direction)
|
Options Plan
52 - Expiration of options
|
$-30,000
-250,000 vol $0.12 each |
0 | |
| Filed 2016-01-13 Tx date 2016-01-11 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-800.00
-4,000 vol $0.20 each |
36,000 | |
| Filed 2015-11-07 Tx date 2015-11-03 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$1,250
+25,000 vol $0.05 each |
40,000 | |
| Filed 2015-11-07 Tx date 2015-11-03 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-1,250
-25,000 vol $0.05 each |
210,000 | |
| Filed 2015-07-10 Tx date 2015-07-06 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
51 - Exercise of options
|
$750.00
+15,000 vol $0.05 each |
15,000 | |
| Filed 2015-07-10 Tx date 2015-07-06 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-750.00
-15,000 vol $0.05 each |
235,000 | |
| Filed 2015-07-10 Tx date 2014-11-18 |
$BCC
The Canadian Bioceutical Corporation |
Layman, David J
4 - Director of Issuer
Holder: Lloyd Layman (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|